当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析 - 现金流量表

凯赛生物

(688065)

  

流通市值:313.45亿  总市值:387.55亿
流通股本:5.83亿   总股本:7.21亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,547,545,586.91701,043,331.962,934,724,311.42,118,997,117.68
  收到的税费返还13,277,594.433,227,370.8860,208,042.7942,425,287.33
  收到其他与经营活动有关的现金251,607,396.3940,493,663.64356,516,611.74294,409,895.55
  经营活动现金流入小计1,812,430,577.73744,764,366.483,351,448,965.932,455,832,300.56
  购买商品、接受劳务支付的现金1,091,270,527.87471,745,419.751,696,480,052.071,282,268,131.64
  支付给职工以及为职工支付的现金142,444,627.7974,582,687.95256,920,942.47195,675,151
  支付的各项税费175,328,990.1788,273,525.68289,353,736216,962,781.26
  支付其他与经营活动有关的现金64,072,576.5722,673,346.19287,764,902.9784,910,278.93
  经营活动现金流出小计1,473,116,722.4657,274,979.572,530,519,633.511,779,816,342.83
  经营活动产生的现金流量净额平衡项目-0.01000
  经营活动产生的现金流量净额339,313,855.3287,489,386.91820,929,332.42676,015,957.73
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额10,023,958.2-20,252,268.7446,199
  收到的其他与投资活动有关的现金400,078,904.11--30,000,000
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计410,102,862.31-20,252,268.7430,046,199
  购建固定资产、无形资产和其他长期资产支付的现金358,235,109.6279,727,020.78843,313,170.45643,949,366.3
  投资支付的现金25,500,00025,500,000--
  支付其他与投资活动有关的现金1,500,000,000---
  投资活动现金流出小计1,883,735,109.6305,227,020.78843,313,170.45643,949,366.3
  投资活动产生的现金流量净额-1,473,632,247.29-305,227,020.78-823,060,901.71-613,903,167.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,967,224,993.635,914,724,993.63--
  其中:子公司吸收少数股东投资收到的现金52,500,000---
  取得借款收到的现金491,288,209.39378,897,583.321,692,844,092.041,098,740,567.5
  收到其他与筹资活动有关的现金--196,446,714.44196,468,347.8
  筹资活动现金流入小计6,458,513,203.026,293,622,576.951,889,290,806.481,295,208,915.3
  偿还债务支付的现金1,806,653,701.05615,493,8001,570,030,601.41,560,509,100.7
  分配股利、利润或偿付利息支付的现金15,124,217.1912,871,162.17140,834,553.68129,446,942.55
  支付其他与筹资活动有关的现金502,327.02-28,933,667.5318,931,870.96
  筹资活动现金流出小计1,822,280,245.26628,364,962.171,739,798,822.611,708,887,914.21
  筹资活动产生的现金流量净额4,636,232,957.765,665,257,614.78149,491,983.87-413,678,998.91
四、汇率变动对现金及现金等价物的影响-4,105,233.672,366,523.9924,824,735.62-28,144,057.36
五、现金及现金等价物净增加额3,497,809,332.125,449,886,504.9172,185,150.2-379,710,265.84
  加:期初现金及现金等价物余额5,185,964,713.125,185,964,713.125,013,779,562.925,013,779,562.92
  期末现金及现金等价物余额8,683,774,045.2410,635,851,218.025,185,964,713.124,634,069,297.08
补充资料:
  净利润284,191,771.38-474,589,331.67-
  资产减值准备57,703,425.03-87,320,261.39-
  固定资产和投资性房地产折旧147,637,368.92-301,056,549.77-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧147,637,368.92-301,056,549.77-
  无形资产摊销10,069,842.78-20,101,234.17-
  长期待摊费用摊销1,837,346.18-4,303,229.92-
  处置固定资产、无形资产和其他长期资产的损失-5,186,013--403,263.87-
  固定资产报废损失--35,149.7-
  公允价值变动损失-2,172,228.69---
  财务费用15,399,686.47--350,771.65-
  投资损失5,951,887.58-8,951,802.66-
  递延所得税-28,638,050.83--51,490,781.23-
  其中:递延所得税资产减少-28,963,885.14--51,490,781.23-
    递延所得税负债增加325,834.31---
  存货的减少-39,253,099.97-198,507,079.25-
  经营性应收项目的减少-159,953,837.79--246,248,690.98-
  经营性应付项目的增加41,731,786.3-22,482,465.51-
  其他3,099,205.14--1,264,832.41-
  现金的期末余额8,683,774,045.24-5,185,964,713.12-
  减:现金的期初余额5,185,964,713.12-5,013,779,562.92-
  现金及现金等价物的净增加额3,497,809,332.12-172,185,150.2-
公告日期2025-08-162025-04-302025-04-222024-10-31
审计意见(境内)标准无保留意见
TOP↑